Need professional-grade analysis? Visit stockanalysis.com
$197.31M
N/A
N/A
N/A
Pacific Edge Limited Ordinary S (PEB) trades on NZX in NZD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at NZD0.18, up 2.86% from the previous close.
Over the past year, PEB has traded between a low of NZD0.08 and a high of NZD0.24. The stock has gained 50.0% over this period. It is currently 25.0% below its 52-week high.
Pacific Edge Limited Ordinary S has a market capitalization of $197.31M.
# Pacific Edge Limited Pacific Edge is a New Zealand-based healthcare diagnostics company that develops and commercializes molecular diagnostic tests, primarily focused on cancer detection and management. The company specializes in urine-based tests for bladder cancer and other urological conditions, leveraging proprietary genomic technology to improve patient outcomes. Pacific Edge operates in the diagnostics and research sector, providing laboratory testing services and diagnostic solutions to healthcare providers.
Side-by-side comparison against top Healthcare peers.